ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.91) by 19.78 percent. This is a 4.29 percent decrease over losses of $(0.70) per share from the same period last year.
Helbiz Kitchen, A Micromobility.com Inc. Company Expands To Austin, TX
Austin becomes the third North American city for Helbiz Kitchen, capitalizing on the existing customer base from its shared mobility and vehicle rental services
